Regional Injection of CAR-T Cells for the Treatment of Refractory and Recurrent Diffuse Large B Cell Lymphoma: A Case Report

BACKGROUND: Lymphoma is a common hematological malignancy with many subtypes and considerable heterogeneity. Traditional treatments include chemotherapy, radiotherapy, and surgery. Patients with relapsed, refractory or advanced stage lymphoma have a dismal prognosis. In recent years, chimeric antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yan-Hui, He, Yu-Zhuo, Lin, Xiao-Yan, Ren, Fu-Xian, Zhu, Hong-Bin, Cheng, Ying, Nan, Zhen, Liu, Zheng-Biao, Yu, Jing-Ya, Guo, Xue-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225683/
https://www.ncbi.nlm.nih.gov/pubmed/32457910
http://dx.doi.org/10.3389/fcell.2020.00333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225683/
https://www.ncbi.nlm.nih.gov/pubmed/32457910
http://dx.doi.org/10.3389/fcell.2020.00333

Ejemplares similares